用人血清白蛋白建立大鼠肝纤维化动物模型,通过光镜与电镜观察,肝胆舒康胶囊可使大鼠肝细胞变性坏死明显减轻,贮脂细胞明显减少,贮脂细胞胞浆、线粒体、液泡明显减少,降低胶原的合成,防治肝维化的形成与发展,与实验空白对照组比P<0.01,证明肝胆舒康胶囊具有防治肝纤维化的作用。 Animal model of hepatic fibrosis was established with human serum albumin. Observed by light microscopy and electron microscopy, hepatic degeneration and necrosis of rat hepatocytes was significantly reduced, and fat-storing cells were significantly reduced, and cytoplasm, mitochondria and vacuoles of lipid-storing cells were preserved. Significantly reduce, reduce the synthesis of collagen and prevent the formation and development of hepatic vascularization. Compared with the experimental control group, P<0.01, it is proved that Gandanshukang capsule can prevent and treat hepatic fibrosis.